How are we changing clinical trials?

How are we changing clinical trials?

How are we changing clinical trials?


Unlearn’s First Ever Webinar Series, Powering Clinical Research with AI, is available On-Demand

This year, Unlearn launched our first-ever, 3 part webinar series, Powering Clinical Research with AI.

Modeling Disease Progression in Mild Cognitive Impairment and Alzheimer's Disease with Digital Twins


Digital Twin Advances Poised to Expand Clinical Trial Reach


What is a Digital Twin?

Let’s go through an aerospace example to illustrate what is required to make a digital twin, how it’s created, and how it’s used.
Digital twins enable faster recruitment with higher powered, individualized trials [capable of generating] additional data from the same or fewer number of patients.
Here, we have demonstrated that a particular type of generative model (i.e., CRBMs) can be used to accurately model disease progression for patients with MCI or AD.

The FDA needs to set standards for using artificial intelligence in drug development

Broadening Role for External Control Arms in Clinical Trials


Using AI Digital Twins for Drug Testing

Dr. Charles Fisher, CEO of Unlearn AI, discusses creating digital clones by using artificial intelligence for use in clinical drug trials.

Transforming Clinical Trials with Intelligent Control Arms


Different Clinical Data, Different Purpose


Can We Find an Exact Match from Historical Data?

Finding matches based on a large number of variables is difficult, often impossible.
To solve the problem of trial inefficiency, clinical trial sponsors are turning to external data sources to supplement and increase efficiency of clinical trials.
Digital twins can be used to populate an intelligent control arm, a type of external control arm with a variety of applications.

Contact us

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.